Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Business Gazette.
Press releases published on May 9, 2025
NI Holdings, Inc. Reports Results for First Quarter Ended March 31, 2025
GlobeNewswire
·
May 9, 2025
FARGO, N.D., May 09, 2025 (GLOBE NEWSWIRE) -- NI Holdings, Inc. (NASDAQ: NODK) announced today results for the quarter ended March 31, 2025. Summary of First Quarter 2025 Results – Continuing Operations (All comparisons vs. continuing operations for the …
Motorsport Games Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 9, 2025
MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or “the Company”) today reported financial results for its first quarter ended March 31, 2025. The Company has also posted the first quarter 2025 earnings …
Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 9, 2025
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration …
Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment
GlobeNewswire
·
May 9, 2025
- Stenoparib continues to demonstrate clinical benefit in heavily pre-treated ovarian cancer, with two patients remaining on treatment for more than 19 months - Initiated utilization of share repurchase program - Cash and restricted cash balance …
Oculis Publishes Invitation to the Annual General Meeting
GlobeNewswire
·
May 9, 2025
ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), today published the invitation to the 2025 Annual General Meeting, which will be held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, …
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
MALVERN, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee …
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
PRINCETON, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
May 9, 2025
JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended March 31, 2025. “ …
Navigator Gas Announces Change to Board of Directors
GlobeNewswire
·
May 9, 2025
LONDON, May 09, 2025 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, announces the following change to …
Tyson Foods Announces Quarterly Dividend
GlobeNewswire
·
May 9, 2025
SPRINGDALE, Ark., May 09, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Tyson Foods (NYSE: TSN), at a meeting on May 8, 2025, declared a quarterly dividend of $0.50 per share on Class A common stock and $0.45 per share on Class B common stock, payable …
Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
GlobeNewswire
·
May 9, 2025
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS); full healthy volunteer data expected in 2H25 On-track to enable dosing ALS patients in late 2025 BOTHELL, Wash., May 09, 2025 ( …
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 30, 2025
GlobeNewswire
·
May 9, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of April 30, 2025, short interest in 3,156 Nasdaq Global MarketSM securities totaled 13,300,707,903 shares compared with 13,211,633,004 shares in 3,143 Global Market issues …
Matador Technologies Inc. Announces Non-Brokered Private Placement
GlobeNewswire
·
May 9, 2025
TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA, OTCQB: MATAF), a Bitcoin-focused technology and investment company, is pleased to announce a non-brokered private placement offering of up to 5, …
Parks! America, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results
GlobeNewswire
·
May 9, 2025
Management to host conference call on Monday, May 12, 2025, at 4:30 PM ET PINE MOUNTAIN, Georgia, May 09, 2025 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCQX: PRKAD), today announced its financial results for the second fiscal quarter ended March 30, 2025 …
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
SAN FRANCISCO, May 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
BRISBANE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on May 5, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 111,750 shares of …
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
GlobeNewswire
·
May 9, 2025
CARLSBAD, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that it has completed the sale of an additional 502,500 shares of its common stock at a public offering price …
Orange Bank & Trust Expands Commitment to Construction and Trade Industries
GlobeNewswire
·
May 9, 2025
MIDDLETOWN, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Orange Bank …
Registration open for MPI’s WEC 2025 in St. Louis; Registrants unlock mystery guest for the closing party
GlobeNewswire
·
May 9, 2025
St. Louis, MO, May 09, 2025 (GLOBE NEWSWIRE) -- Meeting Professionals International (MPI), the world’s largest global meeting and event industry association, has opened registration for its World Education Congress (WEC) 2025, taking place June 18–20 at …
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
WOBURN, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly hired …